New drug can slow the development of Alzheimer's

Scientists have spent 30 years finalising the Lecanemab treatment which can delay the decline in memory associated with Alzheimer's disease.

Following further testing, the drug company will apply for licencing in the US and could be fully accessible within "two to three years".

Read more here: https://news.sky.com/story/lecanemab-new-alzheimers-drug-slows-decline-in-memory-fuelling-hope-doctors-will-one-day-cure-dementia-12758236

#skynews #alzheimer #medicine

SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews

Follow us on Twitter: https://twitter.com/skynews
Like us on Facebook: https://www.facebook.com/skynews
Follow us on Instagram: https://www.instagram.com/skynews
Follow us on TikTok: https://www.tiktok.com/@skynews

For more content go to http://news.sky.com and download our apps:
Apple: https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8
Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB

Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí https://www.youtube.com/channel/skynewsespanol
Sky News videos are also available in German here/Hier können Sie außerdem Sky News-Videos auf Deutsch finden: https://www.youtube.com/channel/UCHYg31l2xrF-Bj859nsOfnA

To enquire about licensing Sky News content, you can find more information here: https://news.sky.com/info/library-sales